Koyfin Home > Directory > Health Care > Aimmune Therap > Cash Flow from Operations

Aimmune Therap Cash Flow from Operations Chart (AIMT)

Aimmune Therap annual/quarterly Cash Flow from Operations from 2014 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Aimmune Therap Cash Flow from Operations for the quarter ending June 06, 2020 was $-55m a 7.73% decrease of -4m year over year
  • Aimmune Therap Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-230m a 15.60% decrease of -36m year over year
  • Aimmune Therap Annual Cash Flow from Operations for 2019 was $-195m a 13.45% decrease of -26m from 2018
  • Aimmune Therap Annual Cash Flow from Operations for 2018 was $-169m a 41.11% decrease of -70m from 2017
  • Aimmune Therap Annual Cash Flow from Operations for 2017 was $-100m a 43.16% decrease of -43m from 2016
Other Cash Flow Metrics:
  • Aimmune Therap Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a 30.11% decrease of -7m year over year
View Chart On Koyfin

Quarterly AIMT Cash Flow from Operations Data

06/2020$-55m
03/2020$-72m
12/2019$-53m
09/2019$-51m
06/2019$-46m
03/2019$-46m
12/2018$-52m
09/2018$-41m
06/2018$-37m
03/2018$-40m

Annual AIMT Cash Flow from Operations Data

2019$-195m
2018$-169m
2017$-100m
2016$-57m
2015$-36m
2014$-10m
2013$-4m